Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Dec;50(12):915–916. doi: 10.1136/ard.50.12.915

Inactivation of the elastase inhibitory activity of alpha 1 antitrypsin in fresh samples of synovial fluid from patients with rheumatoid arthritis.

K Chidwick 1, P G Winyard 1, Z Zhang 1, A J Farrell 1, D R Blake 1
PMCID: PMC1004581  PMID: 1768159

Abstract

The proteinase inhibitory ability of alpha 1 antitrypsin was measured in 23 samples of rheumatoid arthritis synovial fluid, eight osteoarthritic synovial fluids and nine normal control serum samples. For each sample a detailed kinetic analysis was performed with porcine pancreatic elastase as the target proteinase. Samples were stored for less than 24 hours at 4 degrees C before analysis, which does not significantly alter the proportion of inactive alpha 1 antitrypsin. In rheumatoid synovial fluid the elastase inhibitory ability was disproportionately depressed relative to the immunochemically determined concentrations of alpha 1 antitrypsin.

Full text

PDF
915

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Afford S. C., Burnett D., Campbell E. J., Cury J. D., Stockley R. A. The assessment of alpha 1 proteinase inhibitor form and function in lung lavage fluid from healthy subjects. Biol Chem Hoppe Seyler. 1988 Sep;369(9):1065–1074. doi: 10.1515/bchm3.1988.369.2.1065. [DOI] [PubMed] [Google Scholar]
  2. Bieth J., Spiess B., Wermuth C. G. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase. Biochem Med. 1974 Dec;11(4):350–357. doi: 10.1016/0006-2944(74)90134-3. [DOI] [PubMed] [Google Scholar]
  3. Burkhardt H., Kasten M., Rauls S., Rehkopf E. Interference of cartilage surface with interaction of granulocyte elastase with alpha 1-proteinase inhibitor. An in vitro model of enzyme inhibition in the joint space. Rheumatol Int. 1987;7(3):133–138. doi: 10.1007/BF00270466. [DOI] [PubMed] [Google Scholar]
  4. Shtacher G., Maayan R., Feinstein G. Proteinase inhibitors in human synovial fluid. Biochim Biophys Acta. 1973 Mar 23;303(1):138–147. doi: 10.1016/0005-2795(73)90155-4. [DOI] [PubMed] [Google Scholar]
  5. Virca G. D., Mallya R. K., Pepys M. B., Schnebli H. P. Quantitation of human leukocyte elastase, cathepsin G, alpha-2-macroglobulin and alpha-1-proteinase inhibitor in osteoarthrosis and rheumatoid arthritis synovial fluids. Adv Exp Med Biol. 1984;167:345–353. doi: 10.1007/978-1-4615-9355-3_29. [DOI] [PubMed] [Google Scholar]
  6. Weiss S. J. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365–376. doi: 10.1056/NEJM198902093200606. [DOI] [PubMed] [Google Scholar]
  7. Winyard P. G., Pall H., Lunec J., Blake D. R. Non-caeruloplasmin-bound copper ('phenanthroline copper') is not detectable in fresh serum or synovial fluid from patients with rheumatoid arthritis. Biochem J. 1987 Oct 1;247(1):245–246. doi: 10.1042/bj2470245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Wong P. S., Travis J. Isolation and properties of oxidized alpha-1-proteinase inhibitor from human rheumatoid synovial fluid. Biochem Biophys Res Commun. 1980 Oct 16;96(3):1449–1454. doi: 10.1016/0006-291x(80)90113-8. [DOI] [PubMed] [Google Scholar]
  9. Zhang Z., Winyard P. G., Chidwick K., Farrell A., Pemberton P., Carrell R. W., Blake D. R. Increased proteolytic cleavage of alpha 1-antitrypsin (alpha 1-proteinase inhibitor) in knee-joint synovial fluid from patients with rheumatoid arthritis. Biochem Soc Trans. 1990 Oct;18(5):898–899. doi: 10.1042/bst0180898. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES